|
![]() ![]() |
|
![]()
|
|||||||
|
|
When did the Medical Devices Directive become mandatory? The MDD has been enforced since June 15, 1998. In order to meet the Directive, manufacturers must (1) determine the class of their product, (2) comply with the essential requirements, (3) implement the appropriate conformity assessment scheme, and (4) apply the CE Marking and issue a Declaration of Conformity. Yes, if the product has more than one intended function. It is the intended purpose of the device and NOT the particular technical characteristics that determines the class of the product. The best thing to do is to advise the Notified Body of the new product or any new changes. (That is mandatory under the Medical Devices Directive.) However, it may be possible to simply adapt your existing quality system to include these new design changes and/or product additions. Testing on the product will most likely be necessary. Technology International can provide Design Review, providing a Report of necessary actions to take. Annex V is the audit of the Production Process (equivalent to ISO 9002), while Annex VI is Yes, that definitely helps. However, the Notified Body will be auditing your quality system One of the main differences is that the Medical Devices Directive is more comprehensive than most directives. For example, unlike other directives such as the EMC Directive, the Medical Devices Directive ensures that the product performs properly and does what it is intended to do. The EMC Directive, on the other hand, only looks at Electromagnetic Interference; its not concerned with whether or not the product works. The Medical Devices Directive also includes EMC and Low Voltage requirements (If you comply with the MDD, you do not have to comply with other directives) and other labeling specifications. Most medical products are either therapeutic or diagnostic. This criterion is helpful in determining the class of the product, mainly because it allows us to know the intended purpose of the product. Other things to consider are the following: how long the product is to be in contact with the patient (if the product is invasive, how long is it inside the patient?) and if the product is active electronic). | |||||||
|
Technology International Inc., 11311 Business Center Drive, Suite A,
Richmond, VA 23236, USA Phone (804) 794 4144 | Toll Free (800) 810-9000 | Fax (804) 794-4166 Email: rmorgan@techintl.com |
| Copyright © 2010 Technology International |